Yuan Chuchu, Yu Bo, Li Lu, Chen Jinna, Qin Wenhua, Zhou Zhixiang, Su Ming, Wang Die, Zhang Yile, Wu Qian, He Chao, Wei Dangheng
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Department of Pathology, Shenzhen People's Hospital (The Second Clinical Medical College), Jinan University; The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518020, China.
Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113510. doi: 10.1016/j.intimp.2024.113510. Epub 2024 Oct 31.
Atherosclerosis is a progressive inflammatory disease within the large and medium arteries. SUCNR1(Succinate receptor 1) has been reported to regulate the inflammatory response in cardiovascular diseases, but how it works in atherosclerosis remains unclear. In this study, we observed that SUCNR1 is upregulated in endothelial cells within human atherosclerotic lesions. The deletion of SUCNR1 in vascular endothelial cells can mitigate the progression of atherosclerotic lesions in high-fat diet ApoE mice. The overexpression or activation of SUCNR1 intensified endoplasmic reticulum stress and mitochondria-endoplasmic reticulum interactions. Moreover, SUCNR1 exacerbated mitochondrial injury, mtDNA leakage, and the activation of cGAS-STING signaling. Elevated mitochondrial damage, ER-mitochondrial interactions, and inflammation induced by SUCNR1 activation were blocked by the endoplasmic reticulum stress inhibitor. Collectively, these findings suggest that SUCNR1 promotes atherosclerosis through endoplasmic reticulum stress signaling mediated ER-mitochondrial crosstalk and its downstream cGAS-STING pathway. Our results provide new insights into the mechanism of SUCNR1 in atherosclerosis and inhibiting endoplasmic reticulum stress signaling may provide a promising strategy to prevent and treat atherosclerosis.
动脉粥样硬化是一种发生在大中动脉的进行性炎症性疾病。据报道,琥珀酸受体1(SUCNR1)可调节心血管疾病中的炎症反应,但其在动脉粥样硬化中的作用机制尚不清楚。在本研究中,我们观察到SUCNR1在人类动脉粥样硬化病变的内皮细胞中上调。在血管内皮细胞中缺失SUCNR1可减轻高脂饮食ApoE小鼠动脉粥样硬化病变的进展。SUCNR1的过表达或激活会加剧内质网应激和线粒体-内质网相互作用。此外,SUCNR1会加剧线粒体损伤、线粒体DNA泄漏以及cGAS-STING信号的激活。内质网应激抑制剂可阻断SUCNR1激活诱导的线粒体损伤、内质网-线粒体相互作用和炎症。总的来说,这些发现表明,SUCNR1通过内质网应激信号介导的内质网-线粒体串扰及其下游的cGAS-STING途径促进动脉粥样硬化。我们的研究结果为SUCNR1在动脉粥样硬化中的作用机制提供了新的见解,并表明抑制内质网应激信号可能为预防和治疗动脉粥样硬化提供一种有前景的策略。